Novel Mutation in the SLC19A2 Gene in an Iranian Family with Thiamine-Responsive Megaloblastic Anemia: A Series of Three Cases
Thiamine-responsive megaloblastic anemia (TRMA) is a clinical triad characterized by megaloblastic anemia, non-autoimmune diabetes mellitus, and sensory-neural hearing loss. Mutations in the thiamine transporter gene, solute carrier family 19, member 2 (SLC19A2), have been associated with TRMA. Thre...
Main Authors: | Ghaemi, Nosrat, Ghahraman, Martha, Abbaszadegan, Mohammad Reza, Baradaran-Heravi, Alireza, Vakili, Rahim |
---|---|
Format: | Online |
Language: | English |
Published: |
Galenos Publishing
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814536/ |
Similar Items
-
Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia
by: Setoodeh, Aria, et al.
Published: (2013) -
Mitochondria from cultured cells derived from normal and thiamine-responsive megaloblastic anemia individuals efficiently import thiamine diphosphate
by: Song, Qilin, et al.
Published: (2002) -
A novel homozygous SLC19A2 mutation in a Portuguese patient with diabetes mellitus and thiamine-responsive megaloblastic anaemia
by: Tahir, Sophia, et al.
Published: (2015) -
Iron deficiency anemia and megaloblastic anemia in obese patients
by: Arshad Mahmoud, et al.
Published: (2017-03-01) -
Does Early Treatment Prevent Deafness in Thiamine-Responsive Megaloblastic Anaemia Syndrome?
by: Akın, Leyla, et al.
Published: (2011)